| Full Name | Nancy Rosario |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 301 Broadway, Chelsea, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033541388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Rosario, 301 Broadway, Chelsea, MA 02150-2807 Ph: (617) 912-7914 | Nancy Rosario, 301 Broadway, Chelsea, MA 02150-2807 Ph: (617) 912-7914 |
News Archive
Ingenuity® Systems, a leading provider of information solutions for life science researchers, and Geospiza, Inc., the market leading developer of laboratory management and genetic analysis software, today announced a collaboration to enable a seamless next-generation sequencing analysis workflow. The companies will integrate their software products, GeneSifter® and IPA®, to enable researchers to obtain deep biological insights from their project samples through a rapid and reliable workflow to analyze and visualize next-generation sequencing data.
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration approved use of Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal disease in persons 15 years through 55 years of age.
Episodes of lower back pain are not triggered by changes in weather conditions, say Australian researchers.
"There is profound disagreement about healthcare reform's overall impact on jobs. … While the net effect on jobs remains uncertain, it is clear that certain professions will do better than others." Among the specific job categories likely do well are insurance agents, who "may get a boost since approximately 32 million uninsured Americans will be required to buy health insurance starting in 2014.
Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented this afternoon as an oral communication at a late breaking forum of the American Gastroenterological Association Institute during Digestive Disease Week 2010 in New Orleans, Louisiana.
› Verified 9 days ago
Elizabeth Cabrera, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-912-7912 | |
Mr. Manuel De Pena, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-972-7914 | |
Karen Alejandra Salazar, Counselor Medicare: Not Enrolled in Medicare Practice Location: 70 Everett Ave Ste 515, Chelsea, MA 02150 Phone: 617-466-6650 | |
David Lopez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-912-7914 | |
Mistere Ayele, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-912-7914 | |
Kayla Nicole Lyons, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-488-5735 Fax: 617-912-7971 | |
Lesette Wright, Counselor Medicare: Not Enrolled in Medicare Practice Location: 301 Broadway, Chelsea, MA 02150 Phone: 617-912-7914 |